Evolent Health (EVH) Misses Q4 EPS by 9c, Misses on Revenue; Offers FY25 Revenue Guidance

Evolent Health (NYSE: EVH) reported Q4 EPS of ($0.02), $0.09 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $646.5 million versus the consensus estimate of $652.2 million.

GUIDANCE:

Evolent Health sees FY2025 revenue of $2.06-2.11 billion, versus the consensus of $2.42 billion.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Independence Realty Trust (IRT) files mixed shelf